BiOneCure Therapeutics
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.bionecure.comRevenue
<$5 MillionIndustry
About BiOneCure Therapeutics
Is BiOneCure Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if BiOneCure Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BiOneCure Therapeutics recently announced quarterly report
Product Launch: Get notified when BiOneCure Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if BiOneCure Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BiOneCure Therapeutics
Funding: Get notified immidiatlly once BiOneCure Therapeutics has new funding data
Click to see if BiOneCure Therapeutics had a recent Job posting/layoffs
BiOneCure Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined BiOneCure Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to BiOneCure Therapeutics
Compare insights from companies similar to BiOneCure Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BiOneCure Therapeutics
Company Profile Activity
Activity Insights
BiOneCure Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BiOneCure Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BiOneCure Therapeutics.
BiOneCure Therapeutics Tech Stack
A closer look at the technologies used by BiOneCure Therapeutics
BiOneCure Therapeutics News & Media
Marriott's quarterly cash dividend gets healthy jump | Maryland Daily Record
Bethesda-based hospitality giant Marriott International Inc. Monday announced that its board of directors declared a quarterly cash dividend of 52 cents per share of common stock, which represents a 30% increase over the previous quarterly dividend amount of 40 cents per share and reflects the company’s earnings growth and strong cash generation. The dividend is […]BiOneCure Therapeutics and Nanjing Leads Biolabs Join Forces to Develop Innovative Anti-Drug Conjugates (ADCs) for Solid Tumor Treatment
GERMANTOWN, Md., May 15, 2023 /PRNewswire/ -- BiOneCure Therapeutics, Inc. has announced a strategic collaboration with Nanjing Leads Biolabs to develop a range of innovative anti-drug conjugates (ADCs) for treating solid tumors. BiOneCure is a clinical-stage biopharmaceutical company...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BiOneCure Therapeutics
BiOneCure Therapeutics Inc. is a biotechnology company focused on the discovery and development of innovative medicines for cancer treatment. The company aims to provide first-in-class and best-in-class antibody-based therapies to address unmet medical needs in cancer patients. Their research includes a diverse pipeline of antibody drug conjugates... Read More